AevisBio entered into a collaborative research with KRIBB
관리자 │ 2023-01-17
In July of 2019, AevisBio and Korea Research Institute of Bioscience & Biotechnology (KRIBB) announced a collaboration to discover, develop, and commercialize therapies for treating disease of aging, including Parkinson’s disease.
|Previous Post||Bio Research Center founded at Bio Venture Center, KRIBB|
|Next Post||Korean Government grant (TIPS) awarded|